Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Research Progress in Physiological and Pathological Functions of TRAF4. | Front Oncol | 2022 | 35242717 | PubTator, text mining | PubMed |
| Cytoskeletal dynamics regulates stromal invasion behavior of distinct liver cancer subtypes. | Commun Biol | 2022 | 35241781 | PubTator, text mining | PubMed |
| Phase 1 Studies to Evaluate the Food Effect and Relative Bioavailability of Tablet and Capsule Formulations of Belumosudil in Healthy Adult Subjects. | Clin Pharmacol Drug Dev | 2022 | 35238174 | PubTator, text mining | PubMed |
| Gα12 and Gα13: Versatility in Physiology and Pathology. | Front Cell Dev Biol | 2022 | 35237598 | PubTator, text mining | PubMed |
| ADRB3, ROCK2, and GEF Levels in Overactive Bladder Patients. | Int Neurourol J | 2022 | 35236048 | PubTator, text mining | PubMed |
| Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14 C]-Belumosudil in Healthy Men: A Phase 1, Open-Label, 2-Part Study. | Clin Pharmacol Drug Dev | 2022 | 35231159 | PubTator, text mining | PubMed |
| A Phase 1 Pharmacokinetic Drug Interaction Study of Belumosudil Coadministered With CYP3A4 Inhibitors and Inducers and Proton Pump Inhibitors. | Clin Pharmacol Drug Dev | 2022 | 35230741 | PubTator, text mining | PubMed |
| Cell type-specific intercellular gene transfer in mammalian cells via transient cell entrapment. | Cell Discov | 2022 | 35228545 | PubTator, text mining | PubMed |
| Exosomes Mediate APP Dysregulation via APP-miR-185-5p Axis. | Front Cell Dev Biol | 2022 | 35223832 | PubTator, text mining | PubMed |
| Fibroblasts From Idiopathic Pulmonary Fibrosis Induce Apoptosis and Reduce the Migration Capacity of T Lymphocytes. | Front Immunol | 2022 | 35222396 | PubTator, text mining | PubMed |
| Regulatory Roles of the N-Terminal Intrinsically Disordered Region of Modular Src. | Int J Mol Sci | 2022 | 35216357 | PubTator, text mining | PubMed |
| The Induced Expression of BPV E4 Gene in Equine Adult Dermal Fibroblast Cells as a Potential Model of Skin Sarcoid-like Neoplasia. | Int J Mol Sci | 2022 | 35216085 | PubTator, text mining | PubMed |
| Comparative proteomics profiling revealed the involvement of GRB2-ROCK2 axis in Lyme neuroborreliosis caused by Borrelia Burgdorferi. | J Cell Mol Med | 2022 | 35212166 | PubTator, text mining | PubMed |
| The Dual Effect of Rho-Kinase Inhibition on Trabecular Meshwork Cells Cytoskeleton and Extracellular Matrix in an In Vitro Model of Glaucoma. | J Clin Med | 2022 | 35207274 | PubTator, text mining | PubMed |
| Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors. | Cancers (Basel) | 2022 | 35205794 | PubTator, text mining | PubMed |
| Impact of Non-Coding RNAs on Chemotherapeutic Resistance in Oral Cancer. | Biomolecules | 2022 | 35204785 | PubTator, text mining | PubMed |
| Gα12 overexpression in hepatocytes by ER stress exacerbates acute liver injury via ROCK1-mediated miR-15a and ALOX12 dysregulation. | Theranostics | 2022 | 35198058 | PubTator, text mining | PubMed |
| The methyltransferase enzymes KMT2D, SETD1B, and ASH1L are key mediators of both metabolic and epigenetic changes during cellular senescence. | Mol Biol Cell | 2022 | 35196069 | PubTator, text mining | PubMed |
| Carvedilol alleviates lipopolysaccharide (LPS)-induced acute lung injury by inhibiting Ras homolog family member A (RhoA)/ROCK activities. | Bioengineered | 2022 | 35188451 | PubTator, text mining | PubMed |
| Established and Emerging Treatments of Skin GvHD. | Front Immunol | 2022 | 35185931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=50